-transparent.png){kind=logo}
In vitro prostaglandin (PG) and thromboxane B2 (TXB2) formation by isolated glomeruli from normotensive (N) and two-kidney, one-clip hypertensive (2K,1C) rats was determined. When calculated on the basis of glomerular protein content, PGE2, 6-keto-PGF1 alpha and TXB2 production of glomeruli from clipped kidneys was significantly greater than PG and TXB2 formation of glomeruli from the untouched kidneys. When PG and TXB2 formation was calculated per amount of glomeruli, only PGE2 formation was found to be significantly greater in clipped kidneys. No severe damage of glomerular structure was found in the kidneys when studied by light microscopy. In additional in vivo studies, the effect of the cyclooxygenase inhibitor indomethacin on blood pressure and glomerular filtration rate (GFR) was evaluated. Following indomethacin GFR in 7 of 13 clipped kidneys of 2K,1C rats decreased from 363 +/- 77 to 188 +/- 51 microliter/100 g body wt, whereas six kidneys developed anuria. No effect of cyclooxygenase inhibition on GFR was found in N rats and in untouched kidneys of 2K,1C rats. Mean arterial blood pressure in 2K,1C hypertension fell significantly, from 158 +/- 10 to 135 +/- 7 mmHg, after cyclooxygenase inhibition. No effect was seen in N rats. The data suggest that increased glomerular PG formation in the clipped kidneys of 2K,1C rats is involved in the pathogenesis of hypertension in this animal model.
R A Stahl, and
U Helmchen, and
M Paravicini, and
L J Ritter, and
P Schollmeyer
May 1991,
The American journal of physiology,
R A Stahl, and
U Helmchen, and
M Paravicini, and
L J Ritter, and
P Schollmeyer
November 1989,
Journal of hypertension,
R A Stahl, and
U Helmchen, and
M Paravicini, and
L J Ritter, and
P Schollmeyer
October 1989,
Hypertension (Dallas, Tex. : 1979),
R A Stahl, and
U Helmchen, and
M Paravicini, and
L J Ritter, and
P Schollmeyer
February 1983,
Chest,
R A Stahl, and
U Helmchen, and
M Paravicini, and
L J Ritter, and
P Schollmeyer
January 1983,
Clinical and experimental hypertension. Part A, Theory and practice,
R A Stahl, and
U Helmchen, and
M Paravicini, and
L J Ritter, and
P Schollmeyer
August 1990,
Experientia,
R A Stahl, and
U Helmchen, and
M Paravicini, and
L J Ritter, and
P Schollmeyer
March 1983,
Hiroshima journal of medical sciences,
R A Stahl, and
U Helmchen, and
M Paravicini, and
L J Ritter, and
P Schollmeyer
January 1982,
Japanese circulation journal,
R A Stahl, and
U Helmchen, and
M Paravicini, and
L J Ritter, and
P Schollmeyer
July 1986,
Hypertension (Dallas, Tex. : 1979),
R A Stahl, and
U Helmchen, and
M Paravicini, and
L J Ritter, and
P Schollmeyer
January 2013,
Biomedical reports,
